Analgesia and Sedation: Difference between revisions

From Protocopedia
Jump to navigation Jump to search
Line 21: Line 21:
* [[Analgesics|NITROUS OXIDE]] self-administered.
* [[Analgesics|NITROUS OXIDE]] self-administered.
* [[Analgesics|MORPHINE SULFATE]] 2 - 20 mg IV or IN, titrated to effect.
* [[Analgesics|MORPHINE SULFATE]] 2 - 20 mg IV or IN, titrated to effect.
* [[Analgesics|FENTANYL]] 1-2 mcg/kg SLOW IVP or IO, IM, titrated to effect.
'''ANXIETY:'''
'''ANXIETY:'''
* [[Sedative Hypnotics|DIAZEPAM (VALIUM)]] 2 - 20 mg SLOW IVP or IM to desired effect.
* [[Sedative Hypnotics|DIAZEPAM (VALIUM)]] 2 - 20 mg SLOW IVP or IM to desired effect.
Line 42: Line 41:
* [[Sedative Hypnotics|MIDAZOLAM (VERSED)]] 2 - 10 mg IV, IO or IN, titrated to effect
* [[Sedative Hypnotics|MIDAZOLAM (VERSED)]] 2 - 10 mg IV, IO or IN, titrated to effect
* [[Sedative Hypnotics|DIAZEPAM (VALIUM)]] 2 - 20 mg SLOW IVP titrated to effect
* [[Sedative Hypnotics|DIAZEPAM (VALIUM)]] 2 - 20 mg SLOW IVP titrated to effect
* [[Analgesics|FENTANYL]] 1-2 mcg/kg SLOW IVP or IO, IM, titrated to effect.
'''FLANK PAIN/[[Suspected Kidney Stone|SUSPECTED KIDNEY STONES]]:'''
'''FLANK PAIN/[[Suspected Kidney Stone|SUSPECTED KIDNEY STONES]]:'''
* TORADOL (KETOROLAC) 15mg – 30mg IV depending on hydration status
* TORADOL (KETOROLAC) 15mg – 30mg IV depending on hydration status
* [[Analgesics|MORPHINE SULFATE]] 2-20mg IV, IO or IN titrated to effect
* [[Analgesics|MORPHINE SULFATE]] 2-20mg IV, IO or IN titrated to effect
* [[Analgesics|FENTANYL]] 1-2 mcg/kg SLOW IVP or IO, IM, titrated to effect
'''[[Sickle Cell Anemia Crisis|SICKLE CELL ANEMIA CRISIS]]:'''
'''[[Sickle Cell Anemia Crisis|SICKLE CELL ANEMIA CRISIS]]:'''
* [[Analgesics|NITROUS OXIDE]] self administered, as needed for pain
* [[Analgesics|NITROUS OXIDE]] self administered, as needed for pain
Line 54: Line 51:
* [[Analgesics|MORPHINE SULFATE]], 0.1 mg/kg titrate small increments every 20-30 seconds for effect
* [[Analgesics|MORPHINE SULFATE]], 0.1 mg/kg titrate small increments every 20-30 seconds for effect
* [[Sedative Hypnotics|MIDAZOLAM (VERSED)]], 0.1 mg/kg refer to Handtevy System for dosage
* [[Sedative Hypnotics|MIDAZOLAM (VERSED)]], 0.1 mg/kg refer to Handtevy System for dosage
* [[Analgesics|FENTANYL]] 1 mcg/kg SLOW IVP or IO, IM, titrated to effect
'''PROCEDURAL SEDATION: Cardioversion, Pacing, Intubation'''
'''PROCEDURAL SEDATION: Cardioversion, Pacing, Intubation'''
* [[Analgesics|MORPHINE SULFATE]] 2 - 20 mg IV, IO or IN, titrated to effect
* [[Analgesics|MORPHINE SULFATE]] 2 - 20 mg IV, IO or IN, titrated to effect

Revision as of 17:11, 20 November 2017

Section 2 - PRIMARY CARE

2.04 ANALGESIA/SEDATION

"THE BELOW MEDICATIONS MAY ALL CAUSE A DECREASED LOC AND COULD COMPROMISE A PATIENT’S AIRWAY. JUDICIOUS USE IS A MUST! ALLOW AMPLE TIME FOR EACH DOSE TO TAKE EFFECT PRIOR TO ANY ADDITIONAL DOSES BEING ADMINISTERED."

PAIN MANAGEMENT: Moderate to severe pain is an “Emergency Medical Condition”, which historically has been undertreated in EMS. Moderate to severe pain can be described as pain greater than or equal to 6 on the 0-10 pain scale. Pain management should target the two components of pain: physiologic pain, pain receptors and psychologic, anxiety, fear, etc. The treatment of pain and anxiety can be accomplished with narcotic analgesics and benzodiazepines in a safe and reversible manner. The maximal effects of a IV or IO dose of a analgesic or anxiolytic occurs within seconds, not minutes.

Considering the above, a logical approach to pain management in an average-sized adult would be to titrate IV Morphine up to 10 mg then titrate Valium or Versed up to 10 mg. Complications can be reversed by administering Narcan or Romazicon.


PROCEDURE:

  • The numeric rating scale will be used to measure pain on all patients. The numeric rating scale ranges from 0 (no pain) to 10 (unbearable pain).
  • Non-pharmaceutical (BLS) interventions such as: immobilization of fractures; elevation of extremities; ice packs and padding of spine boards and splints should be attempted first, then re-assess the patient.
  • If the pain is still significant (6 or greater) and the patient does not have a contraindication then follow the guidelines below.
  • Vital signs are to be taken before and after the administration of the medication. Appropriate documentation is expected.

ANGINA / MYOCARDIAL INFARCTION:

ACUTE ABDOMINAL PAIN:

ANXIETY:

BURNS: (with moderate to severe pain)

COMBATIVE POST RESUSCITATION / HEAD INJURY:

Note: Morphine should be considered first for combative head injury and suspected MI.

FROST BITE:

MUSCULOSKELETAL PAIN / EXTREMITY PAIN:

FLANK PAIN/SUSPECTED KIDNEY STONES:

  • TORADOL (KETOROLAC) 15mg – 30mg IV depending on hydration status
  • MORPHINE SULFATE 2-20mg IV, IO or IN titrated to effect

SICKLE CELL ANEMIA CRISIS:

PEDIATRIC PATIENTS:

PROCEDURAL SEDATION: Cardioversion, Pacing, Intubation

THE ABOVE MEDICATIONS MAY ALL CAUSE A DECREASED LOC AND COULD COMPROMISE A PATIENT’S AIRWAY. JUDICIOUS USE IS A MUST! ALLOW AMPLE TIME FOR EACH DOSE TO TAKE EFFECT PRIOR TO ANY ADDITIONAL DOSES BEING ADMINISTERED.